Related Experiment Videos
[Physiopathological aspects of secondary hyperuricemia]
1Istituto di Clinica medica e Malattie cardiovascolari, Università, Palermo.
Recenti Progressi in Medicina
|November 1, 1991
Summary
Secondary hyperuricaemia, a condition of elevated uric acid, stems from increased production or reduced renal excretion. Recent findings link various causes to cellular ATP depletion, offering new insights into hyperuricaemia pathogenesis.
Area of Science:
- Biochemistry
- Nephrology
- Hematology
Context:
- Secondary hyperuricaemia presents diverse clinical conditions.
- Pathogenesis involves increased uric acid production or reduced renal excretion.
- Myelo and lymphoproliferative disorders are common causes of overproduction.
Purpose:
- To classify secondary hyperuricaemia based on pathogenetic criteria.
- To explore the underlying mechanisms of hyperuricaemia.
- To identify common pathways in mixed pathogenesis.
Summary:
- Hyperuricaemia can result from overproduction (e.g., myeloproliferative diseases) or under-excretion (e.g., chronic renal failure, diuretics).
- Mixed pathogenesis cases increasingly reveal a shared mechanism involving cellular adenosine triphosphate (ATP) depletion.
- Understanding these diverse causes and mechanisms is crucial for clinical management.
Impact:
- Provides a framework for classifying hyperuricaemia based on its cause.
- Highlights the role of ATP depletion in various hyperuricaemia conditions.
- Informs potential therapeutic strategies targeting common pathogenetic pathways.